Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
July 13, 2024 - The Dermatology Digest
Search

One to Watch: Expanded HyBryte Treatment Produces Positive Outcomes in Early-Stage CTCL

Extended HyBryte treatment for up to 12 months is showing promise in patients with early-stage cutaneous T-cell lymphoma (CTCL), according to an interim update from an open-label, investigator-initiated study (IIS). Soligenix, Inc.’s HyBryte (research name SGX301) is a novel, first-in-class photodynamic therapy that utilizes safe, visible light for activation. The active ingredient in HyBryte is synthetic hypericin, […]